These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27362889)

  • 1. Screening of indeno[1,2-b]indoloquinones by MALDI-MS: a new set of potential CDC25 phosphatase inhibitors brought to light.
    Alchab F; Sibille E; Ettouati L; Bana E; Bouaziz Z; Mularoni A; Monniot E; Bagrel D; Jose J; Le Borgne M; Chaimbault P
    J Enzyme Inhib Med Chem; 2016; 31(sup3):25-32. PubMed ID: 27362889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B.
    Keinan S; Paquette WD; Skoko JJ; Beratan DN; Yang W; Shinde S; Johnston PA; Lazo JS; Wipf P
    Org Biomol Chem; 2008 Sep; 6(18):3256-63. PubMed ID: 18802630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases.
    Evain-Bana E; Schiavo L; Bour C; Lanfranchi DA; Berardozzi S; Ghirga F; Bagrel D; Botta B; Hanquet G; Mori M
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):113-118. PubMed ID: 27774816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a matrix-assisted laser desorption/ionization-mass spectrometry screening test to evidence reversible and irreversible inhibitors of CDC25 phosphatases.
    Sibille E; Bana E; Chaouni W; Diederich M; Bagrel D; Chaimbault P
    Anal Biochem; 2012 Nov; 430(1):83-91. PubMed ID: 22902804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
    Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitors.
    Cossy J; Belotti D; Brisson M; Skoko JJ; Wipf P; Lazo JS
    Bioorg Med Chem; 2006 Sep; 14(18):6283-7. PubMed ID: 16782352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones.
    Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J
    J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25.
    Lazo JS; Aslan DC; Southwick EC; Cooley KA; Ducruet AP; Joo B; Vogt A; Wipf P
    J Med Chem; 2001 Nov; 44(24):4042-9. PubMed ID: 11708908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries.
    Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P
    Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries.
    Jing L; Wu G; Hao X; Olotu FA; Kang D; Chen CH; Lee KH; Soliman MES; Liu X; Song Y; Zhan P
    Eur J Med Chem; 2019 Dec; 183():111696. PubMed ID: 31541869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic small molecule Cdc25 phosphatases inhibitors.
    Garuti L; Roberti M; Pizzirani D
    Curr Med Chem; 2008; 15(6):573-80. PubMed ID: 18336271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
    Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
    J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.
    Lazo JS; Nemoto K; Pestell KE; Cooley K; Southwick EC; Mitchell DA; Furey W; Gussio R; Zaharevitz DW; Joo B; Wipf P
    Mol Pharmacol; 2002 Apr; 61(4):720-8. PubMed ID: 11901209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells.
    Capasso A; Cerchia C; Di Giovanni C; Granato G; Albano F; Romano S; De Vendittis E; Ruocco MR; Lavecchia A
    Oncotarget; 2015 Nov; 6(37):40202-22. PubMed ID: 26474275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate.
    Song Y; Lin X; Kang D; Li X; Zhan P; Liu X; Zhang Q
    Eur J Med Chem; 2014 Jul; 82():293-307. PubMed ID: 24922544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp.
    Cao S; Foster C; Brisson M; Lazo JS; Kingston DG
    Bioorg Med Chem; 2005 Feb; 13(4):999-1003. PubMed ID: 15670907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective Pharmacophore for CDC25 Phosphatases Enzyme Inhibitors: Newly Synthesized Bromothiazolopyrimidine Derivatives.
    El-Shahat M; Salama MAM; El-Farargy AF; Ali MM; Ahmed DM
    Mini Rev Med Chem; 2021; 21(1):118-131. PubMed ID: 32560601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases.
    Huang W; Li J; Zhang W; Zhou Y; Xie C; Luo Y; Li Y; Wang J; Li J; Lu W
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1905-8. PubMed ID: 16434190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7-[corrected](2-morpholin-4-ylethylamino)-quinoline-5,8-dione.
    Pu L; Amoscato AA; Bier ME; Lazo JS
    J Biol Chem; 2002 Dec; 277(49):46877-85. PubMed ID: 12356752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies.
    Rostom SAF; Badr MH; Abd El Razik HA; Ashour HMA
    Eur J Med Chem; 2017 Oct; 139():263-279. PubMed ID: 28803043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.